FHIR

The FHIR community has grown exponentially across the globe because of its ability to scale, while resonating across communities of interest such as patient access and genomics, says Charles Jaffe, CEO of HL7 International.

Kari Hedges, SVP at Blue Cross Blue Shield Association, and Laurent Rotival, SVP at Cambia Health Solutions, say three things are needed: The industry must put patients at the center, use standards like HL7 FHIR and get the entire ecosystem working together.

Grahame Grieve, FHIR product director for HL7 International, says FHIR is key to interoperability and better data access.